[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Contact ::
Main Menu
Home::
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Subscription::
Contact us::
Site Facilities::
::
Search in website

Advanced Search
Receive site information
Enter your Email in the following box to receive the site news and information.
Last site contents
:: Editorial Board
:: About Iranian Journal of Endocrinology and Metabolism
:: Volume 7, Issue 3 (9-2005) ::
2005, 7(3): 223-229 Back to browse issues page
Assessment of thyroid gland of function during interferon alfa therapy in patients with HBV or HCV
F Esfahanian , A Zeyaei , SM Alavian
, sina.tums.ac.ir
Abstract:   (22226 Views)
Aim: To evaluate thyroid gland dysfunction during interferon alfa (INF-alpha) therapy in patients with the hepatitis B ( HBV) and hepatitis C virus (HCV) {BR}, Materials and Methods: 58 patients HCV and 18 patients with HBV were studied prospectively before and at 2 months intervals during INF-alpha therapy. Measurements of serum thyroxine, triiodothyronine, thyrotropine, triiodothyronine resin uptake, thyroid peroxidase antibodies (TPOAbs), and thyroglobulin antibodies (TgAbs) were obtained as were. Thyroid radioactive ioidine uptakes (RAIU) in patients who developed thyroxicosis. Thyroid gland size was evaluated with palpation. {BR} Results: All patients were clinically and biochemically euthyroid prior to INF-alpha therapy. Before treatment, positive levels of TPOAbs and TgAbs were found in 13.8% and 8.6% of patients with HCV compared with 5.5% and 5.5% of patients with HBV, respectively. Titres of TPOAbs increased significantly at the end of INF -alpha therapy in patients with HCV (!0.3%), among whom 5 patients developed hypothyroidism and 1 patient becamed thyrotoxic secondary to thyroiditis with low thyroid RAIU. Patients who developed thyroid gland dysfunction had a higher prevalence of TPOAbs before treatment. Thyroid gland size increased significantly during the study in patients with HBV (p<0.001) and HCV (p<0.005) respectively. {BR}. Conclusions: Thyroid gland dysfunction is not infrequently observed in patients with HCV receiving INF alpha therapy. Systematic screening of thyroid function and TPOAbs titers in all patients with HCV before and during INF-alpha therapy seems warranted are recommended, should INF-alpha have goiterogenic effects further studies are recommended.
Keywords: Hyperthyroidism, Hypothyroidism, Inf-α, Thyroiditism TgAbs, TPO Abs
Full-Text [PDF 184 kb]   (3345 Downloads)    
Type of Study: Original | Subject: Endocrinology
Received: 2007/02/8 | Published: 2005/09/15
Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Esfahanian F, Zeyaei A, Alavian S. Assessment of thyroid gland of function during interferon alfa therapy in patients with HBV or HCV. Iranian Journal of Endocrinology and Metabolism 2005; 7 (3) :223-229
URL: http://ijem.sbmu.ac.ir/article-1-321-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 7, Issue 3 (9-2005) Back to browse issues page
مجله ی غدد درون‌ریز و متابولیسم ایران، دو ماهنامه  پژوهشی مرکز تحقیقات غدد درون‌ریز و متابولیسم، Iranian Journal of Endocrinology and Metabolism
Persian site map - English site map - Created in 0.05 seconds with 38 queries by YEKTAWEB 4645